Cleared Traditional

K141514 - SYNAPSE 3D TENSOR ANALYSIS

K141514 is an FDA 510(k) clearance for SYNAPSE 3D TENSOR ANALYSIS, manufactured by Fujifilm Meidcal Systems U.S.A.,Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 86-day FDA review.

K141514 · Fujifilm Meidcal Systems U.S.A.,Inc. · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2014
Decision
86d
Days
Class 2
Risk

K141514 is an FDA 510(k) clearance for the SYNAPSE 3D TENSOR ANALYSIS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Meidcal Systems U.S.A.,Inc. (Stamford, US). The FDA issued a Cleared decision on September 3, 2014 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K141514

510(k) Number K141514 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 09, 2014
Decision Date September 03, 2014
Days to Decision 86 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 107d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2242
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K141514.
DENTAL IMAGING SOFTWARE
K141607 · Trophy · Sep 2014
EMPRINT PROCEDURE PLANNING APPLICATION
K142048 · Covidien, LLC · Sep 2014
STEREOS WORKSTATION
K141137 · Eos Imaging · Sep 2014
CLIMB MAMMOGRAPHY VIEWER SOFTWARE
K141364 · Climb Medical Systems, Inc. · Aug 2014
VixWin Platinum
K141451 · Imaging Sciences International (Dba Gendex, LLC) · Aug 2014
CVI42
K141480 · Circle Cardiovascular Imaging, Inc. · Aug 2014
K141514 · SYNAPSE 3D TENSOR ANALYSIS
Download PDF FDA Summary Fujifilm Meidcal Syst…